AVIENT CORPORATION (NYSE: AVNT) N O V E M B E R 2 0 2 0 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. INVESTMENT IN COMMERCIAL RESOURCES D R I V E S I N N O VAT I V E P R O D U C T P O R T F O L I O AN D S AL E S G R O W T H 19 160 270 2011 2019 2020E 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 11 12 13 14 15 16 17 18 19 20 21E TARGET NET LEVERAGE BY 2021 ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$350MM PAID OVER LAST 10 YEARS RETURNING VALUE TO SHAREHOLDERS 12 Free Cash Flow Dividends Share Repurchases Deleveraging Strong track record of cash generation put to work in M&A and return to shareholders while modestly levered 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 11 12 13 14 15 16 17 18 19 20 2.9x 2020PF* 2021E Growing Dividend Cumulative Buybacks Net Leverage $ $ p e r s h a re *2020 estimate and Pro forma for acquisition of the Clariant Masterbatch business Cash Generation ~$270MM Another unique value creation lever at Avient is synergy capture with our recent acquisition of Clariant Masterbatch. SEGMENT HIGHLIGHTS 37% 22% 14% Building & Electrical & C O L O R , A D D I T I V E S & I N K S 2020 PF REVENUE | $2 .0 BILLION $9 $320 2005 2020PF 2.0% 15.9% 2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business 32% 39% Latin America END MARKET REGION EBITDA DOLLAR & MARGIN $5 $120 2005 2020E 59% 18% Wire & Cable(1) 25% Electrical & 14% Building & S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2020E REVENUE | $700 MILLION 0.9% 17.1% END MARKET REGION EBITDA DOLLAR & MARGIN 25 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling 30% 24%Packaging Electrical & Building & 1% 79% Latin America END MARKET REGION EBITDA DOLLAR & MARGIN DISTRIBUTION 2020E REVENUE | $ 1 .1 BILLION $20 $70 2005 2020E 2.9% 6.3% KEY SUPPL IER S 26 AMERICAS EUROPE ASIA 26% 13% 16% Building & 5% Electrical & 35% 14%Healthcare 17% Building & Electrical & 32% 26% 12% Building & Electrical & 2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET (58% of sales) (25% of sales) (17% of sales) 27

Onflex-V 1060A-S0003 Black Onflex-V 1065A-S0004 Black Onflex-V 1075A-S0006 Black

DENSO M E C H A N I C A L H V A C D O O R F L A P • Processability was key as the part had to be injection compression molded due to its extremely thin nature • Copper resistance • Light weight • Anti-static • Low VOC • Worked in close collaboration with the customer to understand key design challenges and needs • Streamlined the development process through global presence, working locally in Europe while also running trials in Asia • Re-designed the part to provide a 90% weight reduction • Utilized material science expertise to create a custom formulation that improved resistance to copper deposits and enabled injection compression molding Customized Maxxam™ Formulation KEY REQUIREMENTS WHY AVIENT?

HYPODERMIC NEEDLE MANUFACTURER N E E D L E H U B , C O V E R A N D S H I E L D • Compliance to ISO 6009 color coding for single use hypodermic needle • Biocompatibility of all component materials • Good mechanical and visual properties after sterilization (e.g.

Standard ISO 900 1:2O15 Scope of supply c II +t U t-r- '.F t- () (n rU '- c) l cu q) t_ l m Design, development, marketing & sales and related application support of UHMWPE, Ultra-High-Motecutar-Weight PolyEthytene fibers and UniDirecfionat sheets. Avient Protective Materiats (Heerten) Eisterweg 3, 6422 pN Heerten, The NetherIands Design, devek:pment, marketing & sales and related apptication support of UHA4WPE, Uttra - High -Motecutar-Weigh t PolyEthytene fibers and UniDirectionat sheets Site Address Scope @ EIT:TilU rE:I:.TETCI c t rrl +,t U tr-rf. r- +-t r_ CJ V) CU '(- (.) rii"e r8, 3821 BB Amersfoorr Further ctarifications reqarding.the scope of this certificare 9nd the.dppricabitity of Lhe rnanagement system requirements mav be obrarned bv consurting the organization. i"'ii'"ii'ini, cerrificate variaiiv prease c;r: r31 (0) 88 450 5500 Paae Z of z certificare No: NL027324 tp, R ltfiilt. sy$.

SC-27016-V RED SC-2132 V WHITE SC-2295 V BLACK

SC-1941 V NAT SC-1999 V RED SC-2009 V NAT

SC-1356 V NAT 24766-V OD, SD SC-1421 V RED

© 2019, All Right Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 BUILDING AND CONSTRUCTION SUPPLIER H E A T E X C H A N G E R : G A S R E C O V E R Y • Resistance to corrosion and fouling • Good thermal conductivity • Good pressure resistance • Compatible with current processing methods – extrusion • Eliminated the effects of corrosion and fouling by replacing aluminum • Improved thermal performance over time • Developed a customized solution that utilized the customers existing extrusion processing methods Therma-Tech™ Thermally Conductive Formulation KEY REQUIREMENTS WHY AVIENT?

MEDICAL EQUIPMENT MANUFACTURER C L O S E D S Y S T E M D R U G T R A N S F E R D E V I C E • A new material for a seal inside the next generation of closed system drug transfer device • Compliance with stringent regulatory standards: • Biocompatibility to ISO10993 • USP VI compliance • Provided regulatory support services and expertise throughout extensive medical approval process • Provided a custom formulation compliant with the highest healthcare regulatory standards • Enabled material to be manufactured and shipped globally Custom Versalloy™ HC 9220-90 Formulation KEY REQUIREMENTS WHY AVIENT?